Logo image of WRNT

WARRANTEE INC-ADR (WRNT) Stock Fundamental Analysis

NASDAQ:WRNT - US93465C1062 - ADR

0.2716 USD
0 (-1.2%)
Last: 8/6/2024, 8:03:09 PM
0.283 USD
+0.01 (+4.2%)
After Hours: 8/6/2024, 8:03:09 PM
Fundamental Rating

4

Taking everything into account, WRNT scores 4 out of 10 in our fundamental rating. WRNT was compared to 99 industry peers in the Media industry. WRNT has only an average score on both its financial health and profitability. WRNT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year WRNT was profitable.
WRNT had a positive operating cash flow in the past year.
WRNT Yearly Net Income VS EBIT VS OCF VS FCFWRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of 15.48%, WRNT belongs to the top of the industry, outperforming 95.70% of the companies in the same industry.
The Return On Equity of WRNT (1027.15%) is better than 100.00% of its industry peers.
The Return On Invested Capital of WRNT (41.64%) is better than 98.92% of its industry peers.
Industry RankSector Rank
ROA 15.48%
ROE 1027.15%
ROIC 41.64%
ROA(3y)-16.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRNT Yearly ROA, ROE, ROICWRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 400 600 800 1K

1.3 Margins

Looking at the Profit Margin, with a value of 16.97%, WRNT belongs to the top of the industry, outperforming 91.40% of the companies in the same industry.
WRNT has a better Operating Margin (21.63%) than 94.62% of its industry peers.
Looking at the Gross Margin, with a value of 99.15%, WRNT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of WRNT has grown nicely.
Industry RankSector Rank
OM 21.63%
PM (TTM) 16.97%
GM 99.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.63%
GM growth 5YN/A
WRNT Yearly Profit, Operating, Gross MarginsWRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

4

2. Health

2.1 Basic Checks

WRNT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for WRNT has been reduced compared to 1 year ago.
The debt/assets ratio for WRNT has been reduced compared to a year ago.
WRNT Yearly Shares OutstandingWRNT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
WRNT Yearly Total Debt VS Total AssetsWRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that WRNT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WRNT (0.44) is worse than 67.74% of its industry peers.
WRNT has a debt to FCF ratio of 2.44. This is a good value and a sign of high solvency as WRNT would need 2.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.44, WRNT belongs to the top of the industry, outperforming 81.72% of the companies in the same industry.
WRNT has a Debt/Equity ratio of 17.57. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of WRNT (17.57) is worse than 91.40% of its industry peers.
Although WRNT does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 17.57
Debt/FCF 2.44
Altman-Z 0.44
ROIC/WACC7.64
WACC5.45%
WRNT Yearly LT Debt VS Equity VS FCFWRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M -50M -100M

2.3 Liquidity

WRNT has a Current Ratio of 0.06. This is a bad value and indicates that WRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WRNT (0.06) is worse than 98.92% of its industry peers.
WRNT has a Quick Ratio of 0.06. This is a bad value and indicates that WRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.06, WRNT is not doing good in the industry: 98.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
WRNT Yearly Current Assets VS Current LiabilitesWRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 136.61% over the past year.
WRNT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.25%.
WRNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.54% yearly.
EPS 1Y (TTM)136.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.76%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y61.54%
Revenue growth 5YN/A
Sales Q2Q%-6.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WRNT Yearly Revenue VS EstimatesWRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M 200M

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.16, the valuation of WRNT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as WRNT.
When comparing the Price/Earnings ratio of WRNT to the average of the S&P500 Index (27.03), we can say WRNT is valued inline with the index average.
Industry RankSector Rank
PE 27.16
Fwd PE N/A
WRNT Price Earnings VS Forward Price EarningsWRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as WRNT.
The rest of the industry has a similar Price/Free Cash Flow ratio as WRNT.
Industry RankSector Rank
P/FCF 27.16
EV/EBITDA 13.97
WRNT Per share dataWRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06

4.3 Compensation for Growth

The decent profitability rating of WRNT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for WRNT!.
Industry RankSector Rank
Dividend Yield N/A

WARRANTEE INC-ADR

NASDAQ:WRNT (8/6/2024, 8:03:09 PM)

After market: 0.283 +0.01 (+4.2%)

0.2716

0 (-1.2%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.08M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.16
Fwd PE N/A
P/S 3.68
P/FCF 27.16
P/OCF 21.51
P/B 223
P/tB 223
EV/EBITDA 13.97
EPS(TTM)0.01
EY3.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY3.68%
OCF(TTM)0.01
OCFY4.65%
SpS0.07
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.48%
ROE 1027.15%
ROCE 52.71%
ROIC 41.64%
ROICexc 42.37%
ROICexgc 42.37%
OM 21.63%
PM (TTM) 16.97%
GM 99.15%
FCFM 13.56%
ROA(3y)-16.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.63%
GM growth 5YN/A
F-Score6
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 17.57
Debt/FCF 2.44
Debt/EBITDA 1.01
Cap/Depr 50.48%
Cap/Sales 3.56%
Interest Coverage 17.98
Cash Conversion 59.69%
Profit Quality 79.94%
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 0.44
F-Score6
WACC5.45%
ROIC/WACC7.64
Cap/Depr(3y)824.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)136.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.25%
Revenue growth 3Y61.54%
Revenue growth 5YN/A
Sales Q2Q%-6.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y158.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.64%
OCF growth 3YN/A
OCF growth 5YN/A